143 related articles for article (PubMed ID: 25525841)
1. Chest wall and rib irradiation and toxicities of early-stage lung cancer patients treated with CyberKnife stereotactic body radiotherapy.
Podder T; Biswas T; Yao M; Zhang Y; Kim E; Ellis RJ; Lo SS; Machtay M
Future Oncol; 2014 Dec; 10(15):2311-7. PubMed ID: 25525841
[TBL] [Abstract][Full Text] [Related]
2. Predictors of chest wall toxicity after stereotactic ablative radiotherapy using real-time tumor tracking for lung tumors.
Park Y; Kim HJ; Chang AR
Radiat Oncol; 2017 Apr; 12(1):66. PubMed ID: 28381302
[TBL] [Abstract][Full Text] [Related]
3. Chest wall volume receiving >30 Gy predicts risk of severe pain and/or rib fracture after lung stereotactic body radiotherapy.
Dunlap NE; Cai J; Biedermann GB; Yang W; Benedict SH; Sheng K; Schefter TE; Kavanagh BD; Larner JM
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):796-801. PubMed ID: 19427740
[TBL] [Abstract][Full Text] [Related]
4. Incidence and risk factors for chest wall toxicity after risk-adapted stereotactic radiotherapy for early-stage lung cancer.
Bongers EM; Haasbeek CJ; Lagerwaard FJ; Slotman BJ; Senan S
J Thorac Oncol; 2011 Dec; 6(12):2052-7. PubMed ID: 22052227
[TBL] [Abstract][Full Text] [Related]
5. Quantitative evaluation of correlation of dose and FDG-PET uptake value with clinical chest wall complications in patients with lung cancer treated with stereotactic body radiation therapy.
Algan O; Confer M; Algan S; Matthiesen C; Herman T; Ahmad S; Ali I
J Xray Sci Technol; 2015; 23(6):727-36. PubMed ID: 26756408
[TBL] [Abstract][Full Text] [Related]
6. Radiation-induced rib fracture after stereotactic body radiotherapy with a total dose of 54-56 Gy given in 9-7 fractions for patients with peripheral lung tumor: impact of maximum dose and fraction size.
Aoki M; Sato M; Hirose K; Akimoto H; Kawaguchi H; Hatayama Y; Ono S; Takai Y
Radiat Oncol; 2015 Apr; 10():99. PubMed ID: 25897487
[TBL] [Abstract][Full Text] [Related]
7. Predictors of Chest Wall Toxicity after Lung Stereotactic Ablative Radiotherapy.
Thibault I; Chiang A; Erler D; Yeung L; Poon I; Kim A; Keller B; Lochray F; Jain S; Soliman H; Cheung P
Clin Oncol (R Coll Radiol); 2016 Jan; 28(1):28-35. PubMed ID: 26129745
[TBL] [Abstract][Full Text] [Related]
8. Chest wall toxicity after stereotactic body radiotherapy for malignant lesions of the lung and liver.
Andolino DL; Forquer JA; Henderson MA; Barriger RB; Shapiro RH; Brabham JG; Johnstone PA; Cardenes HR; Fakiris AJ
Int J Radiat Oncol Biol Phys; 2011 Jul; 80(3):692-7. PubMed ID: 21288656
[TBL] [Abstract][Full Text] [Related]
9. Prediction of chest wall toxicity from lung stereotactic body radiotherapy (SBRT).
Stephans KL; Djemil T; Tendulkar RD; Robinson CG; Reddy CA; Videtic GM
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):974-80. PubMed ID: 21300453
[TBL] [Abstract][Full Text] [Related]
10. Predicting chest wall pain from lung stereotactic body radiotherapy for different fractionation schemes.
Woody NM; Videtic GM; Stephans KL; Djemil T; Kim Y; Xia P
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):427-34. PubMed ID: 22197087
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with chest wall toxicity after accelerated partial breast irradiation using high-dose-rate brachytherapy.
Brown S; Vicini F; Vanapalli JR; Whitaker TJ; Pope DK; Lyden M; Bruggeman L; Haile KL; McLaughlin MP
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):801-5. PubMed ID: 22245195
[TBL] [Abstract][Full Text] [Related]
12. Effect of Tumor Location and Dosimetric Predictors for Chest Wall Toxicity in Single-Fraction Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer.
Manyam BV; Videtic GMM; Verdecchia K; Reddy CA; Woody NM; Stephans KL
Pract Radiat Oncol; 2019 Mar; 9(2):e187-e195. PubMed ID: 30529796
[TBL] [Abstract][Full Text] [Related]
13. Chest wall dose in MammoSite breast brachytherapy: radiobiologic estimations of late complication risk based on dose-volume considerations.
Dragun AE; Aguero EG; Harmon JF; Harper JL; Jenrette JM
Brachytherapy; 2005; 4(4):259-63. PubMed ID: 16344255
[TBL] [Abstract][Full Text] [Related]
14. Late chest wall toxicity after MammoSite breast brachytherapy.
Brashears JH; Dragun AE; Jenrette JM
Brachytherapy; 2009; 8(1):19-25. PubMed ID: 18955019
[TBL] [Abstract][Full Text] [Related]
15. Clinical prognostic factors and grading system for rib fracture following stereotactic body radiation therapy (SBRT) in patients with peripheral lung tumors.
Kim SS; Song SY; Kwak J; Ahn SD; Kim JH; Lee JS; Kim WS; Kim SW; Choi EK
Lung Cancer; 2013 Feb; 79(2):161-6. PubMed ID: 23182662
[TBL] [Abstract][Full Text] [Related]
16. Predictors and management of chest wall toxicity after lung stereotactic body radiotherapy.
Shaikh T; Turaka A
Cancer Treat Rev; 2014 Dec; 40(10):1215-20. PubMed ID: 25261888
[TBL] [Abstract][Full Text] [Related]
17. Lung stereotactic ablative radiotherapy (SABR): dosimetric considerations for chest wall toxicity.
Murray L; Karakaya E; Hinsley S; Naisbitt M; Lilley J; Snee M; Clarke K; Musunuru HB; Ramasamy S; Turner R; Franks K
Br J Radiol; 2016; 89(1058):20150628. PubMed ID: 26760508
[TBL] [Abstract][Full Text] [Related]
18. Radiation-induced rib fractures after hypofractionated stereotactic body radiation therapy of non-small cell lung cancer: a dose- and volume-response analysis.
Pettersson N; Nyman J; Johansson KA
Radiother Oncol; 2009 Jun; 91(3):360-8. PubMed ID: 19410314
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Chest Wall Toxicity During Long-term Follow Up After Thoracic Stereotactic Body Radiation Therapy.
Chipko C; Ojwang J; Gharai LR; Deng X; Mukhopadhyay N; Weiss E
Pract Radiat Oncol; 2019 May; 9(3):e338-e346. PubMed ID: 30731275
[TBL] [Abstract][Full Text] [Related]
20. Dose-volume parameters predict for the development of chest wall pain after stereotactic body radiation for lung cancer.
Mutter RW; Liu F; Abreu A; Yorke E; Jackson A; Rosenzweig KE
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1783-90. PubMed ID: 21868173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
